Kim et al. found that HDAC inhibitor CG-745 induces prolonged cytotoxic T cell activation and suppresses M2 macrophage polarization, promoting the effect of PD-1 blockade in mouse models of hepatocellular cancer (6). Here, HDAC9 is linked to hepatocellular carcinoma.